Literature DB >> 2858094

(-)-S-[3H]CGP-12177 and its use to determine the rate constants of unlabeled beta-adrenergic antagonists.

H Affolter, C Hertel, K Jaeggi, M Portenier, M Staehelin.   

Abstract

The enantiomers of the hydrophilic beta-adrenergic blocker CGP-12177 have been synthesized and the S-enantiomer radiolabeled with tritium. The dissociation constant (Kd) of the S-enantiomer for binding to the beta-adrenergic receptor is one-half of that of the racemic mixture and at least 2 orders of magnitude lower than that of the R-enantiomer. The kinetic parameters of the latter were determined by analyzing its effect on the association kinetics of (-)-S-[3H]CGP-12177. A computer program was developed that allows the association and dissociation rate constants of unlabeled ligands to be calculated. This method was validated using Monte Carlo simulations. In addition, the rate constants of unlabeled S-CGP-12177 and S-alprenolol calculated using this method were in good agreement with those of S-[3H]CGP-12177 and S-[3H]dihydroalprenolol, respectively, determined independently. The method was also used to measure the rate constants of the enantiomers of pindolol. These antagonists as well as S- and R-CGP-12177 form their receptor complexes with similar association rate constants. In contrast, the dissociation of the R-enantiomers from receptor-ligand complexes were found to be at least 100 times faster than those of the corresponding S-enantiomers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858094      PMCID: PMC397160          DOI: 10.1073/pnas.82.3.925

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

Review 1.  beta-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase.

Authors:  M E Maguire; E M Ross; A G Gilman
Journal:  Adv Cyclic Nucleotide Res       Date:  1977

2.  [3H]CGP-12177, a beta-adrenergic ligand suitable for measuring cell surface receptors.

Authors:  M Staehelin; C Hertel
Journal:  J Recept Res       Date:  1983

Review 3.  Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

Authors:  G A Weiland; P B Molinoff
Journal:  Life Sci       Date:  1981-07-27       Impact factor: 5.037

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Acetylcholine receptor kinetics. A description from single-channel currents at snake neuromuscular junctions.

Authors:  V E Dionne; M D Leibowitz
Journal:  Biophys J       Date:  1982-09       Impact factor: 4.033

6.  Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes.

Authors:  D Hoyer; G Engel; R Berthold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

7.  Kinetics of the hormone-receptor interaction. Competition experiments with slowly equilibrating ligands.

Authors:  P Arányi
Journal:  Biochim Biophys Acta       Date:  1980-03-03

8.  Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

Authors:  A De Lean; A A Hancock; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

9.  Catecholamine binding to the beta-adrenergic receptor.

Authors:  R J Lefkowitz; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.

Authors:  K Barovsky; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1980
View more
  14 in total

1.  Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.

Authors:  S Kapur; P Seeman
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

2.  Functional efficacy of adenosine A₂A receptor agonists is positively correlated to their receptor residence time.

Authors:  Dong Guo; Thea Mulder-Krieger; Adriaan P IJzerman; Laura H Heitman
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor.

Authors:  Mark R Dowling; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2006-07-10       Impact factor: 8.739

Review 4.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

5.  High density of beta 2-adrenoceptors in a human keratinocyte cell line with complete epidermal differentiation capacity (HaCaT).

Authors:  V Steinkraus; C Körner; M Steinfath; H Mensing
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

6.  Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists.

Authors:  David A Sykes; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

7.  Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations.

Authors:  F Metzger; U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

8.  Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process.

Authors:  L Rabbaa; S Dautrey; N Colas-Linhart; C Carbon; R Farinotti
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

9.  Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.

Authors:  M P Law
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

10.  Increased in vitro expression of beta 2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients.

Authors:  K U Schallreuter; J M Wood; M R Pittelkow; N N Swanson; V Steinkraus
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.